Rice Bioengineers Develop Method to Shield Insulin-Producing Cells
Rice University bioengineers have developed a new method to protect transplanted insulin-producing cells from the body's immune system. The technique utilizes the protein interleukin 10 (IL-10).
Bioengineers at Rice University have developed a novel method to shield transplanted insulin-producing cells from immune system attacks. The technique centers on a protein known as interleukin 10 (IL-10), which acts as a protective barrier.
The research holds promise for new treatment approaches for type 1 diabetes and other autoimmune diseases. The method aims to prevent the immune system from destroying transplanted cells, which are critical for restoring insulin production.
The new approach draws inspiration from natural processes, particularly how certain organisms protect their own tissues. Researchers believe this "biochemical halo" technology could reduce the risk of rejection and improve the long-term efficacy of cell-based therapies.
This advancement may pave the way for new, less invasive treatments, potentially decreasing reliance on immunosuppressive drugs and their associated side effects.